Here we show that the ALS-associated L341V mutation, although previously predicted to represent a benign substitution,18 actually exerts a quantifiable effect on LC3B binding in vitro and affects SQSTM1 recruitment into acidic autophagic vesicles in living cells. The gene discussed is MAP1LC3B; the disease is amyotrophic lateral sclerosis.